Fresenius Kabi USA recalls Fresenius Kabi USA — Dexmedetomidine HCL in 0.9% Sodium Chloride Injection
- Recall date
- November 19, 2020
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Fresenius Kabi USA, Fresenius Kabi USA
Why it was recalled
Cross Contamination with Lidocaine — Impurity
What was recalled
Dexmedetomidine HCL in 0.9% Sodium Chloride Injection
Read the official recall notice →
Get recall alerts
Free email alert whenever Fresenius Kabi USA has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Fresenius Kabi USA, Fresenius Kabi USA